Search

Brain cancer is deadly because it’s so difficult to study. Scientist Luis Parada has developed an innovative model to analyze how brain tumors form and respond to treatment.

… Friday, January 1, 2021 Finding a treatment for brain tumors like glioblastoma (GBM) has been a heartbreaking challenge. The five-year survival rate is less than 10% for patients 45 and older. Because these tumors are relatively rare and located in such a sensitive and well-sheltered part of the body

Researchers have discovered a genetic mechanism that may trigger most childhood cancers.

… Monday, May 15, 2017 Summary Researchers have found that a gene called PGBD5 plays a role in causing many pediatric cancers by creating mutations that turn cells malignant. Cancer is primarily a disease of the aged. A person’s risk rises throughout the years as genetic mutations pile up, due either to

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

… Tuesday, May 27, 2014 Summary David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments. David Solit became a doctor because he wanted to care for patients

Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer. She also made huge strides in reducing the stigma surrounding the disease.

… Tuesday, January 9, 2018 On Christmas Eve, Memorial Sloan Kettering and the wider cancer community lost a beloved and brilliant doctor, Jimmie Holland, who died of cardiovascular disease at 89. Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.

… Monday, September 24, 2018 Summary MSK is improving the lives of people with brain cancer and helping their often stressed-out families. Two of MSK’s top brain cancer experts reflect on how they care for people and recent advances in treatment. There are few diseases as feared — or as challenging to

Meet Christine Iacobuzio-Donahue, a physician-scientist who studies cancer metastasis and is collaborating on genetics research with scientists at the American Museum of Natural History.

… Wednesday, November 29, 2017 Physician-scientist Christine Iacobuzio-Donahue is Interim Director of MSK’s David M. Rubenstein Center for Pancreatic Cancer Research . She studies cancer metastasis and is collaborating on genetics research with scientists at the American Museum of Natural History. You

Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.

… Thursday, April 1, 2021 Americans have a love-hate relationship with sugar. Our favorite foods are full of it, yet nutritionists warn that sugar provides empty calories — good for putting on weight but not much else. Cancer doctors are concerned, too, since obesity is a major risk factor for cancer.

Find out how regular screenings with CT scans can help many people who smoke.

… Tuesday, November 10, 2020 Update: On March 9, 2021, the US Preventive Services Task Force (USPSTF) issued new recommendations to expand screening for lung cancer in people who have a history of smoking but no symptoms of the disease. Under the new guidelines, screening is recommended to begin five years

… Wednesday, May 11, 2022 Barbara (“Barb”) Pemberton has a huge smile, an infectious laugh, and a great memory – she vividly remembers how scared she felt when she interviewed to be a phlebotomist in 2004. As she entered the building for the first time, on her way to “stick” someone to demonstrate her

The lack of participation in clinical research may be the Achilles heel facing today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. For more information or to schedule an interview, please contact [email protected].

… Monday, May 23, 2016 The lack of participation in clinical research may be the Achilles heel facing today’s cancer community.  According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to